GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascentage Pharma Group International (HKSE:06855) » Definitions » PB Ratio

Ascentage Pharma Group International (HKSE:06855) PB Ratio : 171.93 (As of Sep. 24, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Ascentage Pharma Group International PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-09-24), Ascentage Pharma Group International's share price is HK$39.20. Ascentage Pharma Group International's Book Value per Share for the quarter that ended in Dec. 2023 was HK$0.23. Hence, Ascentage Pharma Group International's PB Ratio of today is 171.93.

Warning Sign:

Ascentage Pharma Group International stock PB Ratio (=170.18) is close to 5-year high of 170.18

The historical rank and industry rank for Ascentage Pharma Group International's PB Ratio or its related term are showing as below:

HKSE:06855' s PB Ratio Range Over the Past 10 Years
Min: 1.99   Med: 8.22   Max: 174.57
Current: 170.43

During the past 8 years, Ascentage Pharma Group International's highest PB Ratio was 174.57. The lowest was 1.99. And the median was 8.22.

HKSE:06855's PB Ratio is ranked worse than
99.69% of 1280 companies
in the Biotechnology industry
Industry Median: 2.385 vs HKSE:06855: 170.43

During the past 12 months, Ascentage Pharma Group International's average Book Value Per Share Growth Rate was -86.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -62.80% per year.

During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Ascentage Pharma Group International was -28.70% per year. The lowest was -62.80% per year. And the median was -45.75% per year.

Back to Basics: PB Ratio


Ascentage Pharma Group International PB Ratio Historical Data

The historical data trend for Ascentage Pharma Group International's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascentage Pharma Group International PB Ratio Chart

Ascentage Pharma Group International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial 6.33 8.77 4.90 14.93 119.74

Ascentage Pharma Group International Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.46 14.93 9.48 119.74 -

Competitive Comparison of Ascentage Pharma Group International's PB Ratio

For the Biotechnology subindustry, Ascentage Pharma Group International's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascentage Pharma Group International's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascentage Pharma Group International's PB Ratio distribution charts can be found below:

* The bar in red indicates where Ascentage Pharma Group International's PB Ratio falls into.



Ascentage Pharma Group International PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Ascentage Pharma Group International's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=39.20/0.228
=171.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Ascentage Pharma Group International  (HKSE:06855) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Ascentage Pharma Group International PB Ratio Related Terms

Thank you for viewing the detailed overview of Ascentage Pharma Group International's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ascentage Pharma Group International Business Description

Traded in Other Exchanges
Address
68 Xinqing Road, Suzhou Industrial Park, Jiangsu, Suzhou, CHN, 215000
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis, or programmed cell death. The company's geographical segments include the United States and Mainland China.
Executives
Ascentage Limited
Gao Sharon Xia
Guo Edward Ming
Healthquest Pharma Limited
Li Ju-yun
Wang Shaomeng
Yang Dajun
Zhai Yifan
South Dakota Trust Company Llc 2301 Trustee
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Tian Yuan 2201 Interest of corporation controlled by you
Zhao Li 2202 Interest of your spouse
Xian Jin Zhi Zao Chan Ye Tou Zi Ji Jin You Xian He Huo 2201 Interest of corporation controlled by you
Xian Jin Zhi Zao Chan Ye Tou Zi You Xian Gong Si 2101 Beneficial owner
Guo Tou Chuang Xin Tou Zi Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you

Ascentage Pharma Group International Headlines

No Headlines